|
Hemptown USA, headquartered in Central Point, Oregon, is a proven grower of full-spectrum feminized hemp grown using premium seed genetics that contain less than 0.3% THC and exceptionally high cannabinoid (CBD) content of up to 20%. The company’s “soil to oil” methodology combines seasoned professionals working in hand-picked
agricultural microclimates located in Oregon’s famed Emerald Triangle, Kentucky and Colorado.
Hemptown has rights to 1 million rare CBG (cannabigerol) seeds genetically programmed to yield from 15% to 20% full-spectrum non-intoxicating cannabinoids. Hemptown is positioned to be a leading CBG producer in the U.S. in 2019 and beyond.
In 2018, Hemptown’s harvest from its Oregon hemp farm was 110,000 pounds of full-spectrum biomass with CBD content hovering around 17%. 2018 harvest revenue is expected to range from $8.1 million to $12.6 million. The company is scaling up operations in 2019 to meet market demand and projects it will reap over 1 million pounds. By 2020, Hemptown projects that
potential revenues in the $100 million to $200 million range are possible once additional farming operations are at full strength.
Investment Considerations:
- Superior genetics program with strains high in CBG, CBD and other high-potential cannabinoids
- 1 million rare CBG seeds for the 2019 growing season and beyond
- Biomass producing higher yields with up to 20% full-spectrum CBD and other cannabinoids
- Multistate farming presence in Oregon, Colorado and Kentucky projected to cultivate 2,500 acres by 2020
- Sales and distribution channels include contract wholesale, bulk wholesale, in-house brands and white labeled products
- Disruptive product formulation ensures water solubility, high bioavailability and efficacy
- U.S. hemp-derived CBD sales forecast calls for $22 billion by 2022
|
